Healthcare Equipment and Supplies
Company Overview of Synova Healthcare Group, Inc.
Synova Healthcare Group, Inc., through its subsidiaries, engages in the development, distribution, marketing, and sale of women’s healthcare products. It offers contraception, vaginal health, menopause management, fertility planning, obstetrics, and personal care products. The company’s products include Today Sponge, a non-hormonal contraceptive device that combines barrier and spermicidal methods to prevent conception; Fem-V, a non-invasive diagnostic test designed to assist women in detecting and diagnosing the presence of elevated vaginal acidity, often indicating a vaginal infection; and MenoCheck and MenocheckPro that are in-home and in-office non-invasive diagnostic tests used to detec...
1400 North Providence Road
Media, PA 19063
Founded in 2003
Key Executives for Synova Healthcare Group, Inc.
Synova Healthcare Group, Inc. does not have any Key Executives recorded.
Synova Healthcare Group, Inc. Key Developments
SEC Revokes Registration Of Registered Securities Of Synova Healthcare Group
Oct 2 13
The registration of the registered securities of Synova Healthcare Group, Inc. has been revoked. The Company had repeatedly failed to file required annual and quarterly reports with the Securities and Exchange Commission (SEC). Thus, the Company violated a crucial provision of the federal securities laws that requires public corporations to publicly disclose current, accurate financial information so that investors may make informed decisions. The revocation was ordered in an administrative proceeding before an administrative law judge.
SEC Orders Hearing On Registration Suspension Or Revocation Against Synova Healthcare Group
Sep 10 13
In conjunction with trading suspension, the Securities and Exchange Commission (SEC) also instituted a public administrative proceeding to determine whether to revoke or suspend for a period not exceeding twelve months the registration of each class of the securities of Synova Healthcare Group, Inc. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company is delinquent in its required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and/or 13a-13 there under, are true. The judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in the proceedings issue an initial decision not later than 120 days from the date of service of the order instituting proceeding.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries